Corrigendum to “Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy” [Bioorg. Chem. 129 (2022) 106157]
Titel:
Corrigendum to “Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy” [Bioorg. Chem. 129 (2022) 106157]
Auteur:
Sun, Xin Zhang, Binliang Luo, Leixuan Yang, Yang He, Bin Zhang, Qian Wang, Linxiao Xu, Shan Zheng, Pengwu Zhu, Wufu